Tesamorelin telehealth cost: what providers charge and how to evaluate a quote
Tesamorelin is a GHRH analogue and — importantly — one of the few peptides in this category that is <b>genuinely FDA-approved</b>, though for a narrow indication: the reduction of excess abdominal fat in adults with HIV-associated lipodystrophy. It is marketed as Egrifta. Everything else it is sold for is off-label.
What telehealth providers charge
Publishing an unverified number would be worse than publishing none. When we have captured them, they will appear here with a source and a verification date, exactly like our GLP-1 pricing.
Normalise any quote before you compare it
Because we will not hand you a number we cannot stand behind, the useful thing we can give you is the method — the same one we apply to GLP-1 pricing, where we do hold verified figures.
| Ask for… | Because… |
|---|---|
| The total monthly cost, every fee included | Split billing — medication plus a membership — is the commonest way a price looks lower than it is |
| The ongoing price, not the first month | Introductory rates are customer-acquisition pricing. You pay the ongoing rate eleven months of twelve |
| Whether the price rises with dose | A programme cheapest at the starting dose can be the most expensive at maintenance |
| What happens if you cancel early | On a committed plan this is the question most likely to cost you money |
| Whether labs and shipping are included | 'All-inclusive' is used loosely. Test it against specifics |
| The annual total | Monthly figures are how this is marketed; annual totals are how it is lived |
Providers differ enormously in what happens then. Some refund the unused portion. Some convert you to the month-to-month rate and bill the difference for months already taken. Some refund nothing. This is the single question people most often forget to ask, and it is the one most likely to cost them money.
Frequently asked questions
What does Tesamorelin cost through telehealth?
We have not verified a price and will not publish one we cannot substantiate. This page gives you the method to evaluate any quote you are given.
Is Tesamorelin FDA-approved?
Tesamorelin (Egrifta) is FDA-approved, for one specific indication: excess visceral abdominal fat in HIV-infected patients with lipodystrophy. This is the strongest regulatory position of any peptide on this site, and it deserves to be stated clearly.
It also deserv
Does Tesamorelin work?
The approval rests on real randomised trial data showing a meaningful reduction in visceral adipose tissue in the HIV-lipodystrophy population, with associated improvements in triglycerides. That evidence is good.
It is also specific. There is no comparable trial evide
Sources
- U.S. Food and Drug Administration — approved labels and compounding guidance for this molecule.
- PubMed / NIH — indexed human clinical literature.
- ClinicalTrials.gov — registered trials, where they exist.
- Our source hierarchy and pricing-verification methodology.